IRDAI Flags Rising Consumer Complaints, Seeks Stronger Policyholder Protection
The Insurance Regulatory and Development Authority of India (IRDAI) held a meeting with Chief Compliance Officers and Grievance Redressal Officers of insurance companies to review policyholder protection and grievance handling.
Supratik Roy Takes Charge As CEO Of Spark Minda’s Emerging Business
Spark Minda has appointed Supratik Roy as Chief Executive Officer (CEO) of its Emerging Business division, as shared on his LinkedIn profile.
Reliance Retail Appoints Former Flipkart Executive Jeyandran Venugopal As President & CEO
Jeyandran Venugopal, former Chief Product and Technology Officer at Flipkart, has been appointed President and Chief Executive Officer (CEO) of Reliance Retail Ventures (RRVL).
Citigroup Promotes 276 Employees To Managing Director Roles Across 21 Countries
Citigroup announced the promotion of 276 employees to Managing Director (MD) positions in 2025, the smallest group since 2020.
Ameera Shah Concludes Her Tenure As Independent Director Of ACC
Ameera Shah has completed her term as an Independent Director of ACC Limited and consequently retired with effect from December 2, 2025.
Rakesh Tiwary Replaces Amit Agarwal As CFO Of Raymond
Rakesh Tiwary has been appointed as Group Chief Financial Officer and Key Managerial Personnel (CFO & KMP) of Raymond Limited, effective December 3, 2025.
Lokesh Agarwal Appointed As CFO Of Gujarat State Petronet
Lokesh Agarwal has been appointed as the Chief Financial Officer and Key Managerial Personnel (CFO & KMP) of Gujarat State Petronet Limited, with effect from December 2, 2025.
Meeta Malhotra Joins Sasken Technologies As Independent Director
Meeta Malhotra has been appointed as a Non-Executive Independent Director of Sasken Technologies Limited.
Kartikeya Dube Joins Navin Fluorine International As Independent Director
Kartikeya Dube has been appointed as Non-Executive Independent Director (Additional Director) of Navin Fluorine International Limited, commencing from December 3, 2025, subject to approval of the members of the company.
FDA’s New Drug Division Chief Dr. Richard Pazdur Files For Retirement
Dr. Richard Pazdur, longtime Food and Drug Administration (FDA) oncology Chief, has filed to retire from the agency weeks after being named Director of the Center for Drug Evaluation and Research on November 11, 2025.
